A Phase 1b/2 Study of the Safety and Tolerability of Tinlarebant in Adolescent STGD1 Subjects

被引：0
|
作者：
Grigg, John R. [1 ,2 ]
Chen, Fred Kuanfu [3 ]
Chen, Ta-Ching [4 ]
Jamieson, Robyn V. [1 ,2 ]
Mata, Nathan L. [5 ]
Liao, Webber [6 ]
机构：
[1] Univ Sydney, Save Sight Inst, Sydney, NSW, Australia
[2] Sydney Childrens Hosp Network, Eye Genet Res Unit, Sydney, NSW, Australia
[3] Lions Eye Inst, Nedlands, WA, Australia
[4] Natl Taiwan Univ, Taipei, Taiwan
[5] Belite Bio, San Diego, CA USA
[6] Lin BioSci, Taipei, Taiwan
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2022年 / 63卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
3518
引用
收藏
页数：3
相关论文
共 50 条
  • [1] A Phase 1b/2 Study of the Safety and Tolerability of Tinlarebant in Adolescent Patients Affected by Stargardt Disease-15 month preliminary data
    Grigg, John R.
    Chen, Fred Kuanfu
    Chen, Ta-Ching
    Jamieson, Robyn V.
    Scholl, Hendrik P.
    Mata, Nathan L.
    Quan Dong Nguyen
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [2] Phase 1B study of the safety and tolerability of the mineralocorticoid fludrocortisone acetate in patients with geographical atrophy
    Hong, Thomas
    Chang, Andrew
    Maddess, Ted
    Provis, Jan
    Penfold, Philip
    [J]. BMJ OPEN OPHTHALMOLOGY, 2022, 7 (01):
  • [3] A phase 1B study of the safety and tolerability of the mineralocorticoid fludrocortisone acetate in patients with geographic atrophy
    Hong, Thomas
    Chang, Andrew
    Maddess, Ted
    Provis, Jan
    Penfold, Philip
    [J]. CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2022, 50 (08): : 955 - 955
  • [4] A PHASE 1B/2A STUDY OF THE SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMICS OF XMAB®5871 IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Jaraczewska-Baumann, M.
    Korkosz, M.
    Sulyok, G.
    Sramek, P.
    Rojkovich, B.
    Daniluk, S.
    Bartalos, J.
    Zack, D. J.
    Foster, P.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 481 - 481
  • [5] The PACIFIC Study: A Phase 1b/2a Study to Investigate the Safety, Tolerability, Pharmacology, and Exploratory Efficacy of LP352 in Subjects With Developmental and Epileptic Encephalopathies
    Orevillo, C.
    Bialek, S.
    Dlugos, D.
    French, J.
    Kaye, R.
    [J]. EPILEPSIA, 2023, 64 : 316 - 316
  • [6] A Phase 1b/2a Study to Examine the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TAK-935 as an Adjunctive Therapy in Subjects with Developmental and/or Epileptic Encephalopathies
    Asgharnejad, Mahnaz
    Paker, Asif
    Xu, Rengyi
    Lee, Deborah
    [J]. NEUROLOGY, 2018, 90
  • [7] Phase 1 Study of the Safety, Tolerability, and Pharmacokinetics of Biapenem in Healthy Adult Subjects
    Griffith, David C.
    Morgan, Elizabeth E.
    Dudley, Michael N.
    Loutit, Jeffery S.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2021, 65 (05)
  • [8] A phase 1/1b study of PUR1900, an inhaled formulation of itraconazole, in healthy volunteers and asthmatics to study safety, tolerability and pharmacokinetics
    Hava, David L.
    Tan, Lisa
    Johnson, Patrick
    Curran, Aidan K.
    Perry, Jason
    Kramer, Steve
    Kane, Katie
    Bedwell, Pauline
    Layton, Gary
    Swann, Clarie
    Henderson, Dennis
    Khan, Naimat
    Connor, Lucy
    McKenzie, Litza
    Singh, Dave
    Roach, James
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2020, 86 (04) : 723 - 733
  • [9] Safety, tolerability and treatment effectiveness of chronic hepatitis B patients with pradefovir: a phase 1b multiple ascending dose study
    Jingrui, L.
    Junqi, N.
    Yanhua, D.
    Ning, X.
    Xiaoxue, Z.
    Xiaojiao, L.
    [J]. JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S105 - S105
  • [10] Safety, tolerability, and activity of the active C1s antibody riliprubart in cold agglutinin disease: a phase 1b study
    D'Sa, Shirley
    Vos, Josephine M. I.
    Barcellini, Wilma
    Wardecki, Marek
    Perrin, Laurent
    Barker, Graham
    Zilberstein, Moshe
    Storek, Michael
    Chow, Timothy
    Roeth, Alexander
    [J]. BLOOD, 2024, 143 (08)
12345